SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Quadient S.A. (NPACF) , forward earnings yield 12.32%. PEG 0.69 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
- Forward P/E 8.1
- PEG Ratio 0.69 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
Overall SharesGrow Score: 45/100 with 0/7 criteria passed.
SharesGrow 7-Criteria Score
✗
HEALTH
33/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — NPACF
Valuation Multiples
P/E (TTM)0.0
Forward P/E8.1
PEG Ratio0.69
Forward PEG0.69
P/B Ratio0.00
P/S Ratio0.52
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-1.97
Forward EPS (Est.)$1.94
Book Value / Share$0.00
Revenue / Share$30.07
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Forward Earnings Yield12.32%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2017 |
$2.97 |
$1.16B |
$118.2M |
10.2% |
| 2018 |
$3.35 |
$1.11B |
$133.8M |
12% |
| 2019 |
$2.25 |
$1.09B |
$91.5M |
8.4% |
| 2020 |
$0.15 |
$1.14B |
$5.2M |
0.5% |
| 2021 |
$0.92 |
$1.03B |
$31.5M |
3.1% |
| 2022 |
$2.17 |
$1.02B |
$87.8M |
8.6% |
| 2023 |
$0.29 |
$1.07B |
$9.9M |
0.9% |
| 2024 |
$1.99 |
$1.06B |
$68.7M |
6.5% |
| 2025 |
$1.94 |
$1.09B |
$66.3M |
6.1% |
| 2026 |
$-1.97 |
$1.03B |
$-66.92M |
-6.5% |
